Shaw Christi
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to Shaw Christi. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| KYTX | Award / Grant | 16,634 | — | — | May 29, 2025 | |
| AVTR | Award / Grant | 9,808 | — | — | May 11, 2023 | |
| AVTR | Award / Grant | 6,693 | — | — | May 12, 2022 | |
| AVTR | Award / Grant | 1,215 | — | — | Apr 1, 2022 | |
| AVTR | Award / Grant | 7,236 | — | — | Feb 25, 2021 | |
| AVTR | Sale | 14,286 | $26.68 | $381,150 | Dec 11, 2020 | |
| AVTR | Award / Grant | 11,319 | — | — | Feb 21, 2020 | |
| AVTR | Award / Grant | 14,286 | — | — | May 21, 2019 | |
| LLY | SVP and Pres., Lilly Bio-Meds | Sale | 7,077 | $117.08 | $828,575 | May 3, 2019 |
| LLY | SVP and Pres., Lilly Bio-Meds | Sale | 500 | $117.99 | $58,995 | May 3, 2019 |
| LLY | SVP and Pres., Lilly Bio-Meds | Tax Withholding | 6,173 | $117.04 | $722,488 | May 1, 2019 |
| LLY | SVP and Pres., Lilly Bio-Meds | Sale | 8,426 | $82.10 | $691,775 | May 29, 2018 |
| LLY | SVP and Pres., Lilly Bio-Meds | Sale | 8,426 | $82.10 | $691,775 | May 29, 2018 |
| LLY | SVP and Pres., Lilly Bio-Meds | Tax Withholding | 5,324 | $81.07 | $431,617 | May 1, 2018 |